AML-798: Efficacy and Safety of Gilteritinib Compared to Salvage Chemotherapy for R/R Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis
Department
Internal Medicine
Document Type
Conference Proceeding
Publication Title
Clinical Lymphoma Myeloma and Leukemia
Conference Name
Society of Hematologic Oncology (SOHO) Annual Meeting
Conference Date
2025-09-03 - 2025-09-06
First Page
S459
DOI
10.1016/S2152-2650(25)01728-8
Volume
25
Issue
Supplement 1
Publication Date
9-1-2025
Recommended Citation
Khawar, M. M., Nasir, N., Gill, O., Maqsood, M., Sabir, Z., Arshad, H. M., Tahir, M. U., Gill, N., Khan, M. S., Ahsan, W., Naseem, A., Sehar, A., & Hanif, A. (2025). AML-798: Efficacy and Safety of Gilteritinib Compared to Salvage Chemotherapy for R/R Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis. Clinical Lymphoma Myeloma and Leukemia, 25 (Supplement 1), S459. https://doi.org/10.1016/S2152-2650(25)01728-8
COinS